Cited by 35Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlAutoimmune Neurological Disorders and Treatments

Detection of G protein-coupled receptor autoantibodies in postural orthostatic tachycardia syndrome using standard methodology

Open access
Hall, Juliette, Bourne, Kate M., Vernino, Steven, Hamrefors, Viktor, Kharraziha, Isabella, Nilsson, Jan, Sheldon, Robert S., Fedorowski, Artur +1 more·2022·Circulation

Abstract

Background: Postural orthostatic tachycardia syndrome (POTS) is a disorder of orthostatic intolerance that primarily affects women of childbearing age. The underlying pathophysiology of POTS is not fully understood, but it has been suggested that autoimmunity may play a role. The aim of this study was to compare concentrations of autoantibodies to cardiovascular G protein–coupled receptors between patients with POTS and healthy controls. Methods: Sera were collected from 116 patients with POTS (91% female; medium age, 29 years) and 81 healthy controls (84% female; medium age, 27 years) from Calgary, Canada, and Malmö, Sweden. Samples were evaluated for autoantibodies to 11 receptors (adrenergic, muscarinic, angiotensin II, and endothelin) using a commercially available enzyme-linked immunosorbent assay. Results: Autoantibody concentrations against all of the receptors tested were not significantly different between controls and patients with POTS. The majority of patients with POTS (98.3%) and all controls (100%) had α1 adrenergic receptor autoantibody concentrations above the seropositive threshold provided by the manufacturer (7 units/mL). The proportion of patients with POTS versus healthy controls who fell above the diagnostic thresholds was not different for any tested autoantibodies. Receiver operating characteristic curves showed a poor ability to discriminate between patients with POTS and controls. Conclusions: Patients with POTS and healthy controls do not differ in their enzyme-linked immunosorbent assay–derived autoantibody concentrations to cardiovascular G protein–coupled receptors. These findings suggest that these tests are not useful for establishing the role of autoimmunity in POTS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.122.059971

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [4]Benarroch EE. Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clin Proc. 2012; 87: 1214– 1225. 23122672 PMC3547546
  2. [8]Blitshteyn S Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015; 24: 1364– 1369. 26038344
  3. [10]Gunning WT, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc. 2019; 8: e013602. 31495251 PMC6818019
  4. [11]Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, Zillner C, Benbrook A, Reim S, Collier D, Hill MA, Raj SR, Okamoto LE, Cunningham MW, Aston CE, Kem DC. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014; 3: 1– 10. PMC3959717 24572257
  5. [12]Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J. 2017; 51: 243– 247. 28738696
  6. [13]Yu X, Li H, Murphy TA, Nuss Z, Liles J, Liles C, Aston CE, Raj SR, Fedorowski A, Kem DC. Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018; 7: 1– 7. PMC6015435 29618472
  7. [14]Kharraziha I, Axelsson J, Ricci F, Di Martino G, Persson M, Sutton R, Fedorowski A, Hamrefors V. Serum activity against g protein–coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J Am Heart Assoc. 2020; 9. doi: 10.1161/JAHA.120.015989. PMC7792263 32750291 · DOI · Paper page
  8. [15]Bryarly M, Raj SR, Phillips L, Hynan LS, Okamoto LE, Arnold AC, Paranjape SY, Vernino M, Black BK, Vernino S. Ganglionic Acetylcholine Receptor Antibodies in Postural Tachycardia Syndrome. Neurol Clin Pract. 2021;: 10.1212/CPJ.0000000000001047. PMC8382391 34484936 · DOI
  9. [16]Miglis MG, Muppidi S. Is postural tachycardia syndrome an autoimmune disorder? And other updates on recent autonomic research. Clin Auton Res. 2020; 30: 3– 5. 31938977
  10. [17]Johansson M, Ricci F, Schulte J, Persson M, Melander O, Sutton R, Hamrefors V, Fedorowski A. Circulating levels of growth hormone in postural orthostatic tachycardia syndrome. Sci Rep. 2021; 11: 1– 7. 33883597 PMC8060383
  11. [18]Habibzadeh F, Habibzadeh P, Yadollahie M. On determining the most appropriate test cut-off value: The case of tests with continuous results. Biochem Medica. 2016; 26: 297– 307. PMC5082211 27812299
  12. [19]Carter JV, Pan J, Rai SN, Galandiuk S. ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. Surg (United States). 2016; 159: 1638– 1645. 26962006
  13. [20]Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, Günther J, Lange T, Humrich JY, Klapa S, Schinke S, Schimke LF, Marschner G, Pitann S, Adler S, Dechend R, Müller DN, Braicu I, Sehouli J, Schulze-Forster K, Trippel T, Scheibenbogen C, Staff A, Mertens PR, Löbel M, Mastroianni J, Plattfaut C, Gieseler F, Dragun D, Engelhardt BE, Fernandez-Cabezudo MJ, Ochs HD, al-Ramadi BK, Lamprecht P, Mueller A, Heidecke H, Riemekasten G. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat Commun. 2018; 9. doi: 10.1038/s41467-018-07598-9. PMC6283882 30523250 · DOI
  14. [21]Shapira Y, Katz BSP, Gilburd B, Barzilai O, Ram M, Blank M, Lindeberg S, Frostegård J, Anaya JM, Bizzaro N, Jara LJ, Damoiseaux J, Shoenfeld Y, Levin NA. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol. 2012; 42: 154– 163. 21229335
  15. [22]Badiudeen T, Forsythe EA, Bennett G, Li H, Yu X, Beel M, Nuss Z, Blick KE, Okamoto LE, Arnold AC, Paranjape SY, Black BK, Maxey C, Kem DC, Raj SR. A functional cell-based bioassay for assessing adrenergic autoantibody activity in postural tachycardia syndrome. J Transl Autoimmun. 2019; 2: 100006. 32743496 PMC7388390

Cited by

Sorted by citations

Authors
Hall, J., Bourne, K. M., Vernino, S., Hamrefors, V., Kharraziha, I., Nilsson, J., Sheldon, R. S., Fedorowski, A., & Raj, S. R.
Affiliations
  • University of Calgary (CA)
  • The University of Texas Southwestern Medical Center (US)
  • Skåne University Hospital (SE)
  • Lund University (SE)
  • Karolinska University Hospital (SE)
Corresponding author
Raj, Satish R.
Venue
Circulation
Published
2022-08-23
Volume
146
Issue
8
Pages
613-622
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4283732853
Cited by
35
References
7
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 13 · 2022: 3
FWCI
7.41
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000445)
  • Canadian Institutes of Health Research (42426_1)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
postural orthostatic tachycardia syndrome, autoantibodies, G protein-coupled receptors, autoimmunity, alpha1-adrenoceptors, muscarinic receptors, angiotensin II receptor, endothelin receptors, orthostatic intolerance, diagnostic biomarkers, enzyme-linked immunosorbent assay
MeSH terms
Adult, Autoantibodies, Female, Heart Rate, Humans, Male, Autoimmunity, Receptors, G-Protein-Coupled, Orthostatic Intolerance, Postural Orthostatic Tachycardia Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review